Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
A CCR2+ myeloid cell niche required for pancreatic β cell growth
Kristin Mussar, … , Vincenzo Cirulli, Laura Crisa
Kristin Mussar, … , Vincenzo Cirulli, Laura Crisa
Published August 3, 2017
Citation Information: JCI Insight. 2017;2(15):e93834. https://doi.org/10.1172/jci.insight.93834.
View: Text | PDF
Research Article Development Endocrinology

A CCR2+ myeloid cell niche required for pancreatic β cell growth

  • Text
  • PDF
Abstract

Organ-specific patterns of myeloid cells may contribute tissue-specific growth and/or regenerative potentials. The perinatal stage of pancreas development marks a time characterized by maximal proliferation of pancreatic islets, ensuring the maintenance of glucose homeostasis throughout life. Ontogenically distinct CX3CR1+ and CCR2+ macrophage populations have been reported in the adult pancreas, but their functional contribution to islet cell growth at birth remains unknown. Here, we uncovered a temporally restricted requirement for CCR2+ myeloid cells in the perinatal proliferation of the endocrine pancreatic epithelium. CCR2+ macrophages are transiently enriched over CX3CR1+ subsets in the neonatal pancreas through both local expansion and recruitment of immature precursors. Using CCR2-specific depletion models, we show that loss of this myeloid population leads to a striking reduction in β cell proliferation, dysfunctional islet phenotypes, and glucose intolerance in newborns. Replenishment of pancreatic CCR2+ myeloid compartments by adoptive transfer rescues these defects. Gene profiling identifies pancreatic CCR2+ myeloid cells as a prominent source of IGF2, which contributes to IGF1R-mediated islet proliferation. These findings uncover proproliferative functions of CCR2+ myeloid subsets and identify myeloid-dependent regulation of IGF signaling as a local cue supporting pancreatic proliferation.

Authors

Kristin Mussar, Stephanie Pardike, Tobias M. Hohl, Gary Hardiman, Vincenzo Cirulli, Laura Crisa

×

Figure 8

Adoptive transfer of DT-resistant CCR2+ cells reconstitutes the pancreatic CCR2+ myeloid pool.

Options: View larger image (or click on image) Download as PowerPoint
Adoptive transfer of DT-resistant CCR2+ cells reconstitutes the pancreat...
(A) FACS analysis of myeloid populations used for adoptive transfer, and time line of cell and DT injections. Adoptively transferred populations were GR1+ CD3–B220–CD11c–Ter119– cells isolated from BM of C57BL/6-Tg(CAG-EGFP)10sb/J or CCR2WT/RFP reporter mice, purified to >97% by negative selection, or CCR2-RFP+ cells FACS sorted from GR1+ cells based on RFP expression in the depicted gate. (B) Contingency plots showing the relative representation of host- and donor-derived CD11b+CCR2+ myeloid cells in BM, spleen, and pancreas after reconstitution of DT-treated WT and CCR2DTR/+ mice with DT-resistant GR1+GFP+ cells (mean ± SEM of n = 3–6 tissue samples per group and tissue type). (C) Body weight and basal glycemia in P10 WT and CCR2DTR/+ mice treated with DT and simultaneously rescued with DT-resistant GR1+GFP+ cells. *P < 0.05, unpaired t test. (D) Flow cytometry plots of BM and splenic and pancreatic CD11b+ myeloid cells from DT-treated CCR2DTR/+ WT mice (P10) reconstituted with DT-resistant GR1+GFP+ cells. Gating on GFP+ cells (bottom row) demonstrates a substantial fraction of CCR2+ cells of donor origin in the pancreas. Representative of n = 3 experiments.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts